These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35037778)

  • 1. Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.
    Wyatt H; Zuckerman AD; Hughes ME; Arnall J; Miller R
    J Oncol Pharm Pract; 2022 Apr; 28(3):627-634. PubMed ID: 35037778
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-system specialty pharmacy role and outcomes: A review of current literature.
    Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
    Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services.
    Zuckerman AD; Mourani J; Smith A; Ortega M; Donovan JL; Gazda NP; Tong K; Simonson D; Kelley T; DeClercq J; Choi L; Pierce G
    Am J Health Syst Pharm; 2023 Jun; 80(13):827-841. PubMed ID: 36999452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
    Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
    J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy.
    Zuckerman AD; Shah NB; Peter ME; Jolly JA; Kelley TN
    Am J Health Syst Pharm; 2021 May; 78(11):972-981. PubMed ID: 33693451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
    Bagwell A; Kelley T; Carver A; Lee JB; Newman B
    J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
    Gutenschwager DW; Patel A; Soyad AT; Patel S; Szandzik EG; Kelly B; Smith ZR
    Am J Health Syst Pharm; 2024 Jan; 81(2):66-73. PubMed ID: 37611180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
    Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
    [No Abstract]   [Full Text] [Related]  

  • 9. Droxidopa management by an integrated health-system specialty pharmacy team.
    Livezey SN; Shah NB; DeClercq J; Keefe J; Choi L; Shibao C; Zuckerman AD
    J Am Pharm Assoc (2003); 2022; 62(6):1904-1911. PubMed ID: 35787811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
    Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
    J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
    [No Abstract]   [Full Text] [Related]  

  • 11. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an integrated pharmacist collaborative care model in specialty disease state clinics.
    Stroedecke N; Lee J; Stutsky M; Boothe K; Tong K; Luon S; Sawant V; Renauer M
    Am J Health Syst Pharm; 2022 Nov; 79(22):2047-2052. PubMed ID: 35913890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
    Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
    J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
    [No Abstract]   [Full Text] [Related]  

  • 14. Specialty pharmacy turnaround time impediments, facilitators, and good practices.
    Gabriel MH; Kotschevar CM; Tarver D; Mastrangelo V; Pezzullo L; Campbell PJ
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1244-1251. PubMed ID: 36282928
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of embedding a pharmacist in a dermatology clinic on outcomes in a specialty pharmacy.
    Penick T; Hawkins T; O'Reilly E; Maniyar H; Maier C; McPheeters C
    J Am Pharm Assoc (2003); 2023; 63(2):661-666. PubMed ID: 36464555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.
    Looney B; Crumb J; White S; Jones G; Moore RP; Choi L; Zuckerman AD; Whelchel K
    J Manag Care Spec Pharm; 2024 May; 30(5):465-474. PubMed ID: 38701029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
    Smith AT; Kennerly-Shah JM; Kusoski CL
    J Oncol Pharm Pract; 2020 Oct; 26(7):1686-1694. PubMed ID: 32865162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
    McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
    Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASHP National Survey of Health-System Specialty Pharmacy Practice-2020.
    Stubbings J; Pedersen CA; Low K; Chen D
    Am J Health Syst Pharm; 2021 Sep; 78(19):1765-1791. PubMed ID: 34345889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-system specialty pharmacy: Overview of a hybrid clinical model.
    Meadors C; McPheeters C; Maier C; O'Reilly E
    Am J Health Syst Pharm; 2024 Apr; 81(9):e256-e260. PubMed ID: 38146967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.